Variants of SCCmec with CRISPR-Cas in MRSA Evade Rapid Diagnostic Tests

Overview

A study identified 64 SCCmec variants associated with CRISPR-Cas in MRSA that evade detection by rapid molecular assays, affecting approximately 2% of screened isolates. These variants, primarily in clonal complex 5 hospital-associated MRSA, cause false-negative results by disrupting primer binding at the SCCmec–orfX junction.

Background

Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of healthcare-associated infections with high mortality despite treatment. Rapid PCR-based assays like Xpert and BCID2 detect MRSA by targeting mecA and SCCmec sequences to guide timely therapy. However, sequence variations in SCCmec or its junction with orfX can disrupt assay primers, leading to false negatives and delayed appropriate treatment. CRISPR-Cas systems, rare in S. aureus but present in SCCmec elements, may contribute to such diagnostic escape.

Data Highlights

Key Findings

• CRISPR-Cas–associated SCCmec variants disrupt primer binding at the SCCmec–orfX junction, causing false-negative results in rapid MRSA assays.
• These variants were identified in 2% of MRSA isolates screened, predominantly in clonal complex 5 hospital-associated strains.
• Rapid diagnostic assays BCID2 and Xpert failed to detect 11 of 40 variant SCCmec/junction sequences tested.
• Variants exhibited mecA instability and were circulating in healthcare settings, indicating potential for spread.
• Current rapid molecular tests relying on conserved SCCmec sequences may underestimate MRSA prevalence due to these variants.

Clinical Implications

Clinicians should be aware that rapid molecular assays may yield false-negative MRSA results due to emerging SCCmec variants with CRISPR-Cas elements. Confirmatory culture and susceptibility testing remain essential, especially in hospital-associated infections. Genomic surveillance is critical to monitor and update diagnostic assays to maintain accuracy and guide appropriate antimicrobial therapy.

Conclusion

CRISPR-Cas–associated SCCmec variants represent a unique mechanism of diagnostic escape in MRSA, compromising the reliability of rapid molecular assays. Ongoing genomic monitoring and assay refinement are necessary to ensure accurate detection and effective patient management.

References

1. Article Source 2024 -- Variants of SCCmec Associated with CRISPR-Cas in MRSA Overcome Rapid Diagnostic Methods